Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


1 Arch Esp Urol
1 Cancer Res
1 Clin Genitourin Cancer
1 Cochrane Database Syst Rev
1 Eur Urol Focus
2 Int Braz J Urol
1 Int J Infect Dis
1 J Ethnopharmacol
1 J Urol
1 Nat Cell Biol
1 Toxicol Appl Pharmacol
1 Urology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Arch Esp Urol

  1. VALLEJO-BENITEZ A, Rodriguez-Zarco E, Pabon-Carrasco S, Espinal PS, et al
    [Small cell bladder carcinoma in age extremes: Report of two cases.]
    Arch Esp Urol. 2018;71:204-207.
    PubMed     Text format     Abstract available

    Cancer Res

  2. CHEN A, Fu G, Xu Z, Sun Y, et al
    Detection of Bladder Cancer Via Microfluidic Immunoassay and Single-Cell DNA Copy Number Alteration Analysis of Captured Urinary Exfoliated Tumor Cells.
    Cancer Res. 2018 May 22. pii: 0008-5472.CAN-17-2615.
    PubMed     Text format     Abstract available

    Clin Genitourin Cancer

  3. KAYAMA E, Kikuchi E, Fukumoto K, Shirotake S, et al
    History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy.
    Clin Genitourin Cancer. 2018 Apr 28. pii: S1558-7673(18)30303.
    PubMed     Text format     Abstract available

    Cochrane Database Syst Rev

  4. BENNETT MH, Feldmeier J, Smee R, Milross C, et al
    Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
    Cochrane Database Syst Rev. 2018;4:CD005007.
    PubMed     Text format     Abstract available

    Eur Urol Focus

  5. MICHELS CTJ, Wijburg CJ, Leijte E, Witjes JA, et al
    A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future research.
    Eur Urol Focus. 2018 May 18. pii: S2405-4569(18)30104.
    PubMed     Text format     Abstract available

    Int Braz J Urol

  6. TURAN T, Efiloglu O, Gunaydin B, Ozkanli S, et al
    Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder.
    Int Braz J Urol. 2018;44:267-272.
    PubMed     Text format     Abstract available

  7. TANG S, Hao H, Fang D, Zheng W, et al
    Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center.
    Int Braz J Urol. 2018;44:258-266.
    PubMed     Text format     Abstract available

    Int J Infect Dis

  8. BILSEN MP, van Meijgaarden KE, de Jong HK, Joosten SA, et al
    A novel view on the pathogenesis of complications after intravesical BCG for bladder cancer.
    Int J Infect Dis. 2018 May 17. pii: S1201-9712(18)34414.
    PubMed     Text format     Abstract available

    J Ethnopharmacol

  9. YUEN JWM, Mak DSY, Chan ES, Gohel MDI, et al
    Tumor inhibitory effects of intravesical Ganoderma lucidum instillation in the syngeneic orthotopic MB49/C57 bladder cancer mice model.
    J Ethnopharmacol. 2018 May 18. pii: S0378-8741(18)31199.
    PubMed     Text format     Abstract available

    J Urol

  10. MAZZA P, Moran GW, Li G, Robins DJ, et al
    Conservative Management Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study.
    J Urol. 2018 May 19. pii: S0022-5347(18)43234-X. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available

    Nat Cell Biol

  11. WEBER C
    A biobank for bladder cancer.
    Nat Cell Biol. 2018 May 21. pii: 10.1038/s41556-018-0114.
    PubMed     Text format    

    Toxicol Appl Pharmacol

  12. JIN CY, Molagoda IMN, Karunarathne WAHM, Kang SH, et al
    TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells.
    Toxicol Appl Pharmacol. 2018 May 21. pii: S0041-008X(18)30233.
    PubMed     Text format     Abstract available


  13. TAPIERO S, Helfand A, Kedar D, Yossepowitch O, et al
    Patient Compliance with Maintenance Intravesical Therapy for Non-Muscle Invasive Bladder Cancer.
    Urology. 2018 May 21. pii: S0090-4295(18)30473.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.